Now Available from CCO Oncology
Treatment Update
Through a CME-certified educational module and Interactive Case Challenges, CCO's expert faculty members review the latest data on the treatment of myelodysplastic syndromes and explore realistic clinical situations.
CME-certified Module:
CME-certified Case Challenges:
CCO Conference Coverage
Treatment Update
CCO Conference Coverage
CCO's independent coverage of the 2008 Gastrointestinal Cancers Symposium includes 3 CME-certified Conference Reports and an accompanying downloadable slideset focusing on key presentations at the conference.
CCO Conference Coverage
CCO's robust independent coverage of the 2007 ASH meeting includes downloadable slidesets, Capsule Summaries of key presentations, Expert Analyses on specific indications, and brief audio Expert Highlights from our faculty discussing the key issues in hematologic malignancies highlighted at the conference. Our major conference tracks include:
-
-
Multiple Myeloma
Kenneth Anderson, MD; Sagar Lonial, MD; and Robert Z. Orlowski, MD, PhD
-
-
Acute Leukemias
Dan Douer, MD; Stephen J. Forman, MD; and Hagop M. Kantarjian, MD
-
-
Treatment Update
Through 4 CME-certified educational modules, CCO’s expert faculty members review the latest data on the treatment of melanoma.
Genetics and Molecular Pathogenesis of Melanoma: Current Understanding
|

|
Hensin Tsao, MD, PhD, provides an expert overview of new insights into the genetic predisposition to melanoma, the molecular pathogenesis of the disease, and its evasion of immune system response. Click here to begin.
|
Diagnosis and Staging of Melanoma: Evolving Practice
|

|
Jeffrey E. Gershenwald, MD, FACS, provides an overview and update on current and emerging approaches to characterizing melanoma in individual patients, including pathologic staging and sentinel lymph node biopsy.
|
Treatment of Melanoma: Current Best Practice
|

|
Sanjiv S. Agarwala, MD, reviews current therapeutic options for patients with melanoma across the continuum of progression, from localized to metastatic disease. Click here to begin.
|
Exploring New Directions in Melanoma Treatment
|

|
Keith T. Flaherty, MD, reviews cutting edge research for treatment of advanced melanoma, including immunotherapies, antibodies, and chemotherapeutic combinations.
|
Treatment Update
Through 8 CME-certified slidesets, CCO's expert faculty members, including Program Directors Dennis J. Slamon, MD, PhD, and John Crown, MD, MPH, review the latest data based on translational research in oncology that were presented at the International Translational Research in Oncology meeting held in Dublin, Ireland, in October 2007.
|

|
Session I: Growth Factors and Growth Factor Receptors
Dennis J. Slamon, MD, PhD
|
|

|
Session II: Steroid Hormonal Receptors and Their Manipulation
Mitchell Dowsett, MD, PhD
|
|
|
Session III: Apoptosis and Programmed Cell Death
Gerry Melino, MD, PhD
|
|

|
Session IV: Malignant Angiogenesis and Antiangiogenic Therapies
Fairooz Kabbinavar, MD
|
|

|
Session V: Signal Transduction: Targets in the Malignant Signaling Process
Spiros Linardopoulos, PhD
|
|

|
Session VI: Immunotherapies and Vaccine Strategies
John Glaspy, MD
|
|

|
Session VII: Malignant Stem Cells as Targets in Oncology
Hasan Korkaya, PhD
|
|

|
Session VIII: New Approaches to Pathway Identification, Predictive/Prognostic Factors, and Biologic imaging
John Crown, MD, MPH
|
Treatment Update
This series of CME-certified Expert Recaps and accompanying downloadable slidesets provides a comprehensive update on the use of targeted treatments and biomarkers to optimize patient outcomes in metastatic colorectal cancer. Developed with Clinical Care Options' expert faculty members, these slidesets are available for use as a self-study resource or in your own presentations.
Treatment Update
More Treatment Updates
CCO Journal Options for Oncology
More CCO Independent Conference Coverage
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
More Management Series
More Interactive Case Challenges
Cutaneous T-Cell Lymphoma
|
Browse Oncology
New Data
Slidesets
Bookstore
Cases
Expert Commentary
from our Advisory Board & leading experts
Journal Options for June 2007
Sagar Lonial, MD
Associate Professor of Hematology and Oncology
Director, Translational Research B-cell Malignancy Program
The Winship Cancer Institute
Emory University
Atlanta, Georgia
Expert Viewpoint for October 2007
Al B. Benson III, MD
Professor, Division of Hematology/Oncology
Feinberg School of Medicine at Northwestern University
Chicago, Illinois
|